Skip to content

Bupivacaine Epiphora Trial

Improving Epiphora & Ptosis With Bupivacaine

Status
Withdrawn
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03266081
Enrollment
0
Registered
2017-08-29
Start date
2015-04-30
Completion date
2022-08-23
Last updated
2022-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epiphora, Ptosis

Brief summary

The objective of this study is to investigate quantitative improvement in excessive tearing after administration of Bupivacaine, a local anesthetic, into the affected eyelids.

Interventions

topical anesthetic

Sponsors

McMaster University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Patients age 18 and above, patients with unilateral or bilateral excessive tearing.

Exclusion criteria

Pregnant females, vulnerable populations, patients with severe hepatic disease, or patients using monoamine oxidase inhibitors or tricyclic antidepressants, which are contraindicated with bupivacaine and norepinephrine combinations.

Design outcomes

Primary

MeasureTime frameDescription
Change from Baseline Lacrimal Tear Lake at 6 monthsmeasurements at baseline and 6 monthsMeasurement of the height (in mm) of the tear film in the lower conjunctival cup de sac, obtained during slit lamp examination of the eye

Secondary

MeasureTime frameDescription
Change from baseline Lid distraction at 6 monthsmeasurements at baseline and 6 monthsdistance (in mm) that the eyelids can be maximally pulled from the globe
Change from baseline Lid snap back at 6 monthsmeasurements at baseline and 6 monthsAmount of time (in sec) it takes for the lids to return to their normal anatomical position after being pulled to their maximum excursion with fingers

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026